Banff Sport Medicine, Banff, Alberta, Canada.; Department of Surgery, University of Calgary, Calgary, Alberta, Canada.
Banff Sport Medicine, Banff, Alberta, Canada.; Department of Physical Therapy, University of Alberta, Edmonton, Alberta, Canada.
Orthop J Sports Med. 2016 May 11;4(5):2325967116646085. doi: 10.1177/2325967116646085. eCollection 2016 May.
The Banff Patella Instability Instrument (BPII) is a disease-specific, patient-reported, quality-of-life outcome measure designed to assess patients with patellofemoral instability. The iterative assessment of the validity, reliability, and responsiveness of a health-related patient-reported outcome measure is vital to the development of a high-quality evaluation tool.
To assess the concurrent validity of the BPII to the Norwich Patellar Instability (NPI) score and the Kujala score.
Cohort study; Level of evidence, 2.
A total of 74 patients with a confirmed diagnosis of recurrent patellofemoral instability completed the BPII, NPI, and Kujala scores at the initial orthopaedic consultation. A Pearson r correlation coefficient was computed to determine the relationship between each of these patient-reported outcomes.
There were statistically significant correlations between the BPII and the NPI score (r = -0.53; P < .001) as well as the BPII and the Kujala score (r = 0.50; P < .001).
This study demonstrated a moderately strong correlation of the BPII to other outcome measures used to evaluate patients with patellofemoral instability. This study adds further validity to the BPII in accordance with the COSMIN (COnsensus-based Standards for the selection of health Measurement INstruments) guidelines.
Banff 髌股不稳仪器(BPII)是一种针对髌股不稳患者的疾病特异性、患者报告的生活质量评估工具。对健康相关的患者报告结局评估工具进行有效性、可靠性和反应性的迭代评估对于开发高质量的评估工具至关重要。
评估 BPII 与诺维奇髌股不稳(NPI)评分和 Kujala 评分的同时效度。
队列研究;证据水平,2 级。
共有 74 例经证实的复发性髌股不稳患者在初次骨科就诊时完成了 BPII、NPI 和 Kujala 评分。计算 Pearson r 相关系数以确定这些患者报告结局之间的关系。
BPII 与 NPI 评分(r = -0.53;P <.001)以及 BPII 与 Kujala 评分(r = 0.50;P <.001)之间存在统计学显著相关性。
本研究表明,BPII 与用于评估髌股不稳患者的其他结局测量具有中度强相关性。这项研究根据 COSMIN(健康测量工具选择的共识标准)指南进一步证明了 BPII 的有效性。